The American Heart Association has launched IMPLEMENT-Lipid Management™, a three-year implementation science initiative designed to help healthcare organizations identify, test, and share practical strategies for strengthening lipid management in real-world clinical settings. The initiative brings together a cohort of 10 cardiology and primary care organizations in a national learning collaborative focused on understanding care delivery challenges, examining current treatment pathways, and identifying operational strategies that may help improve lipid management workflows and therapy optimization.
The need is significant: despite the availability of effective therapies and evidence-based treatment guidance, the majority of people at risk for cardiovascular disease do not achieve recommended cholesterol levels. Clinical workflow complexities, treatment escalation challenges, referral processes, prior authorization requirements, and patient engagement barriers can all affect access to timely, guideline-directed care.
“Clinicians have effective tools to manage lipid disorders, yet healthcare teams often encounter challenges that can make delivering optimal care difficult,” said Nishant Shah, M.D., principal investigator for IMPLEMENT-Lipid Management, volunteer member of the American Heart Association’s Outpatient Quality Improvement Advisory Group, and associate professor of medicine in cardiology at Duke University and Duke Clinical Research Institute. “The American Heart Association’s IMPLEMENT-Lipid Management will help identify practical solutions that work within existing clinical environments and create opportunities to share those learnings with healthcare teams nationwide.”
Participating organizations will analyze key aspects of lipid management, including healthy lifestyle recommendations, treatment initiation and escalation pathways, referral practices, patient barriers to care, clinician workflows, and care coordination processes. Through quality improvement consultation and peer-to-peer learning, participants will evaluate approaches that may help reduce care gaps and support evidence-based treatment. The initiative is grounded in implementation science, which focuses on understanding how evidence-based practices can be effectively integrated into routine care. By examining how care is delivered across diverse practice settings, participants will help identify scalable strategies that support patient-clinician communication, shared decision-making, and access to evidence-based therapies.
The 10 sites preparing to participate in the initiative are: Altru Family Medicine Center, in Grand Forks, N.D.; Chinese Hospital, in San Francisco; Emory Clinic Cardiology, in Atlanta; Family Health Centers of Southwest Florida, in Lehigh Acres, Fla.; Finger Lakes Community Health, in Geneva, N.Y.; Heart of Ohio Family Health, in Columbus, Ohio; Lone Star Family Health Center, in Conroe, Texas; Southwest Health Family Medicine Associates, in Platteville, Wisc.; University of Colorado Hospital Cardiometabolic and Advanced Lipid Clinic, in Aurora, Colo.; and University of Pittsburgh Medical Center Heart and Vascular Institute Lipid Clinic, in Pittsburgh.
The initiative is financially supported by Merck & Co., Inc. “Collaboration and shared learning are essential to advancing patient care,” said Bjorn Oddens, M.D., senior vice president and head of value and implementation, Merck Research Laboratories. “Merck is proud to support IMPLEMENT-Lipid Management and its efforts may strengthen lipid management practices and improve care to help more people living with high cholesterol reach their LDL cholesterol goals.”
Insights generated through the initiative will be shared broadly through professional education resources, webinars, conference presentations, and other dissemination activities. Lessons learned may also help inform future enhancements to the Association’s outpatient quality improvement efforts, enabling more healthcare organizations to adopt proven strategies for improving lipid management and cardiovascular health outcomes. For more information, visit heart.org. Additional resources include the 2026 Guideline on the Management of Dyslipidemia and the ASCVD Professional Education Tool Kit.
This initiative matters because cardiovascular disease remains a leading cause of death, and improving lipid management can significantly reduce the risk of heart attacks and strokes. By addressing real-world barriers and fostering collaboration among diverse healthcare settings, IMPLEMENT-Lipid Management aims to create scalable solutions that can be adopted nationwide, ultimately helping more patients achieve optimal cholesterol levels and better health outcomes.

